NuGen Medical Devices Overview
- Year Founded
-
2017
- Status
-
Public
- Stock Symbol
-
NGMD
- Investments
-
2
- Share Price
-
$0.07
- (As of Tuesday Closing)
NuGen Medical Devices General Information
Description
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Europe followed by Asia, North America and others.
Contact Information
Website
www.nugenmd.comCorporate Office
- 18 King Street East
- Suite 1400
- Toronto, Ontario M5C 1C4
- Canada
Corporate Office
- 18 King Street East
- Suite 1400
- Toronto, Ontario M5C 1C4
- Canada
NuGen Medical Devices Timeline
NuGen Medical Devices Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.07 | $0.07 | $0.06 - $0.11 | $14.4M | 218M | 225K |
NuGen Medical Devices Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 20,748 | 22,303 | 7,403 | 24,590 |
Revenue | 256 | 245 | 117 | 110 |
EBITDA | (3,942) | (5,480) | (3,002) | (4,058) |
Net Income | (5,634) | (6,932) | (4,281) | (5,666) |
Total Assets | 4,535 | 5,236 | 5,047 | 6,937 |
Total Debt | 6,016 | 5,943 | 5,457 | 4,399 |
NuGen Medical Devices Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
NuGen Medical Devices Executive Team (6)
Name | Title | Board Seat |
---|---|---|
Ian Heynen | Chief Executive Officer | |
Richard Buzbuzian | Board Member & President | |
Veronique Laberge | Chief Financial Officer, Finance & Secretary, Administration | |
Nicky Canton | Chief Operating Officer, Operations | |
Claude Vezeau | Director of clinical research and Chief Scientist |
NuGen Medical Devices Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Self | Board Member | ||
NuGen Medical Devices | Board Member & Executive | ||
NuGen Medical Devices | Board Member & President | ||
Self | Board Member |
NuGen Medical Devices Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
NuGen Medical Devices Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Insujet | 19-May-2020 | Medical Supplies | |||
4 Touchdowns Capital | 06-Oct-2017 | Merger/Acquisition | Holding Companies |
NuGen Medical Devices Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Insujet | Medical Supplies | Hong Kong, Hong Kong |
NuGen Medical Devices FAQs
-
When was NuGen Medical Devices founded?
NuGen Medical Devices was founded in 2017.
-
Who is the CEO of NuGen Medical Devices?
Ian Heynen is the CEO of NuGen Medical Devices.
-
Where is NuGen Medical Devices headquartered?
NuGen Medical Devices is headquartered in Toronto, Canada.
-
What industry is NuGen Medical Devices in?
NuGen Medical Devices’s primary industry is Drug Delivery.
-
Is NuGen Medical Devices a private or public company?
NuGen Medical Devices is a Public company.
-
What is NuGen Medical Devices’s stock symbol?
The ticker symbol for NuGen Medical Devices is NGMD.
-
What is the current stock price of NuGen Medical Devices?
As of 08-Oct-2024 the stock price of NuGen Medical Devices is $0.07.
-
What is the current market cap of NuGen Medical Devices?
The current market capitalization of NuGen Medical Devices is $14.4M.
-
What is NuGen Medical Devices’s current revenue?
The trailing twelve month revenue for NuGen Medical Devices is $256K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »